OBJECTIVE:Transcranial direct current stimulation (tDCS) has been shown to improve pain symptoms in fibromyalgia (FM), a central pain syndrome whose underlying mechanisms are not well understood. This study was undertaken to explore the neurochemical action of tDCS in the brain of patients with FM, using proton magnetic resonance spectroscopy (1H-MRS). METHODS:Twelve patients withFM underwent sham tDCS over the left motor cortex (anode placement) and contralateral supraorbital cortex (cathode placement) for 5 consecutive days, followed by a 7-day washout period and then active tDCS for 5 consecutive days. Clinical pain assessment and 1H-MRS testing were performed at baseline, the week following the sham tDCS trial, and the week following the active tDCS trial. RESULTS:Clinical pain scores decreased significantly between the baseline and active tDCS time points (P = 0.04). Levels of glutamate + glutamine (Glx) in the anterior cingulate were significantly lower at the post–active tDCS assessment compared with the post–sham tDCS assessment (P = 0.013), and the decrease in Glx levels in the thalami between these time points approached significance (P = 0.056). From baseline to the post–sham tDCS assessment, levels of N-acetylaspartate (NAA) in the posterior insula increased significantly (P = 0.015). There was a trend toward increased levels of γ-aminobutyric acid (GABA) in the anterior insula after active tDCS, compared with baseline (P = 0.064). Baseline anterior cingulate Glx levels correlated significantly with changes in pain score, both for the time period from baseline to sham tDCS (β1 = 1.31, P < 0.001) and for the time period from baseline to active tDCS (β1= 1.87, P < 0.001). CONCLUSION: The present findings suggest that GABA, Glx, and NAA play an important role in the pathophysiology of FM and its modulation by tDCS.
RCT Entities:
OBJECTIVE: Transcranial direct current stimulation (tDCS) has been shown to improve pain symptoms in fibromyalgia (FM), a central pain syndrome whose underlying mechanisms are not well understood. This study was undertaken to explore the neurochemical action of tDCS in the brain of patients with FM, using proton magnetic resonance spectroscopy (1H-MRS). METHODS: Twelve patients with FM underwent sham tDCS over the left motor cortex (anode placement) and contralateral supraorbital cortex (cathode placement) for 5 consecutive days, followed by a 7-day washout period and then active tDCS for 5 consecutive days. Clinical pain assessment and 1H-MRS testing were performed at baseline, the week following the sham tDCS trial, and the week following the active tDCS trial. RESULTS: Clinical pain scores decreased significantly between the baseline and active tDCS time points (P = 0.04). Levels of glutamate + glutamine (Glx) in the anterior cingulate were significantly lower at the post–active tDCS assessment compared with the post–sham tDCS assessment (P = 0.013), and the decrease in Glx levels in the thalami between these time points approached significance (P = 0.056). From baseline to the post–sham tDCS assessment, levels of N-acetylaspartate (NAA) in the posterior insula increased significantly (P = 0.015). There was a trend toward increased levels of γ-aminobutyric acid (GABA) in the anterior insula after active tDCS, compared with baseline (P = 0.064). Baseline anterior cingulate Glx levels correlated significantly with changes in pain score, both for the time period from baseline to sham tDCS (β1 = 1.31, P < 0.001) and for the time period from baseline to active tDCS (β1= 1.87, P < 0.001). CONCLUSION: The present findings suggest that GABA, Glx, and NAA play an important role in the pathophysiology of FM and its modulation by tDCS.
Authors: Bradley R Foerster; Myria Petrou; Richard A E Edden; Pia C Sundgren; Tobias Schmidt-Wilcke; Suzan E Lowe; Steven E Harte; Daniel J Clauw; Richard E Harris Journal: Arthritis Rheum Date: 2012-02
Authors: M Petrou; R E Harris; B R Foerster; S A McLean; A Sen; D J Clauw; P C Sundgren Journal: AJNR Am J Neuroradiol Date: 2008-03-13 Impact factor: 3.825
Authors: Richard E Harris; Vitaly Napadow; John P Huggins; Lynne Pauer; Jieun Kim; Johnson Hampson; Pia C Sundgren; Bradley Foerster; Myria Petrou; Tobias Schmidt-Wilcke; Daniel J Clauw Journal: Anesthesiology Date: 2013-12 Impact factor: 7.892
Authors: Richard E Harris; Pia C Sundgren; A D Craig; Eric Kirshenbaum; Ananda Sen; Vitaly Napadow; Daniel J Clauw Journal: Arthritis Rheum Date: 2009-10
Authors: Kentaro Oki; Niladri K Mahato; Masato Nakazawa; Shinichi Amano; Christopher R France; David W Russ; Brian C Clark Journal: J Gerontol A Biol Sci Med Sci Date: 2016-02-24 Impact factor: 6.053
Authors: L Becerra; R Veggeberg; A Prescot; J E Jensen; P Renshaw; S Scrivani; E L H Spierings; R Burstein; D Borsook Journal: Neuroimage Clin Date: 2016-03-31 Impact factor: 4.881
Authors: Manyoel Lim; Dajung J Kim; Thiago D Nascimento; Eric Ichesco; Chelsea Kaplan; Richard E Harris; Alexandre F DaSilva Journal: Neuromodulation Date: 2021-07-26
Authors: Alexandre F DaSilva; Dennis Q Truong; Marcos F DosSantos; Rebecca L Toback; Abhishek Datta; Marom Bikson Journal: Front Neuroanat Date: 2015-07-15 Impact factor: 3.856
Authors: Chelsea M Cummiford; Thiago D Nascimento; Bradley R Foerster; Daniel J Clauw; Jon-Kar Zubieta; Richard E Harris; Alexandre F DaSilva Journal: Arthritis Res Ther Date: 2016-02-03 Impact factor: 5.156